T1	Treatment 20 29	rituximab
T2	Treatment 172 205	tumor necrosis factor inhibitors:
T3	Treatment 409 424	rituximab (RTX)
T4	Treatment 502 541	tumor necrosis factor (TNF) inhibitors.
T5	Treatment 599 680	placebo (PBO) + methotrexate (MTX; PBO-randomized) or RTX + MTX (RTX-randomized).
T6	Treatment 774 777	RTX
T7	Treatment 810 813	RTX
T8	Treatment 923 926	RTX
T9	Treatment 967 981	RTX-randomized
T10	Treatment 1075 1078	RTX
T11	Treatment 1201 1215	RTX-randomized
T12	Treatment 1269 1274	1 RTX
T13	Treatment 1762 1781	both PBO-randomized
T14	Treatment 1791 1809	and RTX-randomized
T15	Treatment 1886 1925	in PBO-randomized versus RTX-randomized
T16	Treatment 1951 1978	CONCLUSION RTX re-treatment
T17	Treatment 2147 2171	initiating RTX treatment
